 | MorphoSys (NYSE:MOR) Trading Down 0.4%
americanbankingnews.com - September 16 at 1:22 AM |
 | Biotech Report: MorphoSys (MOR) und MagForce sacken ab
finanznachrichten.de - September 9 at 4:12 AM |
 | MorphoSys reports 1H results
seekingalpha.com - August 5 at 8:44 PM |
 | MorphoSys Posts Wider Loss In Q2, Revenues Down 47%; Confirms 2020 Guidance
nasdaq.com - August 5 at 8:44 PM |
| MorphoSys FDA Approval, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - August 3 at 12:36 PM |
| Xencor gets $25M milestone payment from MorphoSys
seekingalpha.com - August 2 at 2:49 PM |
| FDA OKs Incyte/Morphosys' tafasitamab for treatment-resistant lymphoma
seekingalpha.com - August 1 at 8:50 AM |
| MorphoSys-Aktie leicht im Plus
www.finanznachrichten.de - July 31 at 10:49 PM |
| Biotech Report: Sektor schwächer, MorphoSys (MOR) geben wieder ab, Gilead Sciences (GILD) verlieren
www.finanznachrichten.de - July 31 at 10:49 PM |
 | FDA Approves Monjuvi® (tafasitamab-cxix) in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
finance.yahoo.com - July 31 at 10:49 PM |
|
| MorphoSys AG: Ad hoc: FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
finance.yahoo.com - July 31 at 10:49 PM |
| FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
finance.yahoo.com - July 31 at 10:49 PM |
| wikifolio whispers p.m. zu BASF, Deutsche Wohnen, MorphoSys ...
www.finanznachrichten.de - July 30 at 3:36 PM |
| Aktienmarkt: Aktie von MorphoSys kann sich nicht behaupten
www.finanznachrichten.de - July 30 at 3:36 PM |
 | Sjogren’s Syndrome Pipeline Insights, 2020
www.marketwatch.com - July 19 at 10:47 PM |
 | Galapagos NV: Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
www.bloomberg.com - July 15 at 12:57 AM |
| FDA Approves Janssen's Tremfya For Treatment Of Adults With Active Psoriatic Arthritis
www.nasdaq.com - July 15 at 12:57 AM |
| Nasdaq Welcomes MorphoSys AG (Nasdaq: MOR) to The Nasdaq Stock Market
www.bloomberg.com - July 9 at 9:39 PM |
| MorphoSys AG: MorphoSys and Incyte Announce the Validation of the European Marketing Authorization Application for Tafasitamab
www.finanznachrichten.de - May 21 at 7:45 AM |
 | MorphoSys and Incyte Announce the Validation of the European Marketing Authorization Application for Tafasitamab (news with additional features)
uk.finance.yahoo.com - May 20 at 8:48 PM |
 | Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for Tafasitamab
www.businesswire.com - May 20 at 3:46 PM |
| EMA accepts MorphoSys application for tafasitamab for type of blood cancer
seekingalpha.com - May 20 at 3:46 PM |
| MorphoSys to Present Data on Tafasitamab at the ASCO and EHA Virtual Meetings (news with additional features)
uk.finance.yahoo.com - May 15 at 12:03 AM |
| MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patients with r/r DLBCL (news with additional features)
uk.finance.yahoo.com - May 15 at 12:03 AM |
| MorphoSys up 3% on long-term tafasitamab data in blood cancer
seekingalpha.com - May 14 at 1:59 PM |
 | BRIEF-Morphosys And Incyte Announce Follow-Up Results From Study Of Tafasitamab
www.reuters.com - May 14 at 1:59 PM |
| MorphoSys to Present Data on Tafasitamab at the ASCO and EHA Virtual Meetings
finance.yahoo.com - May 14 at 1:59 PM |
| Hematological Malignancies Disease Market 2020 by Regions, Manufactures, Type, Application, Sales, Revenue and Forecast to 2026
www.marketwatch.com - May 11 at 9:18 AM |
|
| MorphoSys AG 2020 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 10 at 5:34 PM |
| Do Its Financials Have Any Role To Play In Driving MorphoSys AG's (ETR:MOR) Stock Up Recently?
finance.yahoo.com - May 9 at 4:28 PM |
| BRIEF-Morphosys Reports Q1 Revenue 251.2 Mln EUR Versus 13.5 Mln EUR Year Ago
www.reuters.com - May 7 at 8:11 AM |
| DGAP-News: MorphoSys Reports First Quarter 2020 Results
www.bloomberg.com - May 6 at 6:27 PM |
| MorphoSys Reports Profit In Q1; Affirms Guidance - Quick Facts
www.nasdaq.com - May 6 at 6:27 PM |
| MorphoSys Reports First Quarter 2020 Results
finance.yahoo.com - May 6 at 6:27 PM |
| Axsome Shares Jump 25% on Alzheimer's Study Results
finance.yahoo.com - April 28 at 11:18 AM |
| I-Mab and MorphoSys Announce First Patient Dosed in Phase 3 Clinical Trial of TJ202/MOR202 in r/r Multiple Myeloma in Mainland
www.bloomberg.com - April 27 at 6:40 PM |
| MorphoSys and I-Mab Announce First Patient Dosed in Phase 3 Clinical Trial of MOR202/TJ202 in r/r Multiple Myeloma in
www.bloomberg.com - April 27 at 6:40 PM |
| MorphoSys and I-Mab Announce First Patient Dosed in Phase 3 Clinical Trial of MOR202/TJ202 in r/r Multiple Myeloma in Mainland China
finance.yahoo.com - April 27 at 6:40 PM |
| Is MorphoSys AG (MOR) Going to Burn These Hedge Funds?
finance.yahoo.com - April 6 at 10:00 PM |
| MorphoSys says coronavirus impacting clinical studies and business
finance.yahoo.com - April 6 at 5:00 PM |
| BRIEF-Morphosys FY Revenue 71.8 Million EUR Versus 76.4 Million EUR Year Ago
www.reuters.com - March 19 at 11:30 PM |
| MorphoSys AG 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 19 at 1:28 PM |
| MorphoSys AG to Host Earnings Call
finance.yahoo.com - March 19 at 1:28 PM |
| Invitation to MorphoSys' Year-End Results 2019 Conference Call on March 19, 2020
finance.yahoo.com - March 12 at 6:09 PM |
| Incyte wins OK to provide $750M payment for drug collaboration
finance.yahoo.com - March 5 at 2:26 PM |
| MorphoSys, Incyte Receive Antitrust Clearance For Collaboration On Tafasitamab
www.nasdaq.com - March 3 at 11:04 PM |
| BRIEF-Morphosys, Incyte Announce Antitrust Clearance Of Global Collaboration And License Agreement For Tafasitamab
www.reuters.com - March 3 at 6:03 PM |
| Antitrust watchdog OK with MorphoSys - Incyte tafasitamab partnership
seekingalpha.com - March 3 at 6:03 PM |
| MorphoSys and Incyte Announce Antitrust Clearance of Global Collaboration and License Agreement for Tafasitamab
finance.yahoo.com - March 3 at 6:03 PM |
| Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates on Key Clinical Programs
www.businesswire.com - February 13 at 9:11 AM |
